Korsana Biosciences’ preclinical Alzheimer’s illness drug comes from a platform expertise that permits antibodies to cross the blood-brain barrier. Roche and AbbVie have clinical-stage medication taking an identical method to Alzheimer’s.
The submit Startup Korsana Bio Reveals $175M Raised for a Higher Mind-Penetrating Alzheimer’s Drug appeared first on MedCity Information.
